Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VONOPRAZAN vs VORAPAXAR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VONOPRAZAN vs VORAPAXAR: Safety Overview

Metric VONOPRAZAN VORAPAXAR
Total FAERS Reports 2,019 189
Deaths Reported 73 12
Death Rate 3.6% 6.3%
Hospitalizations 342 45
Average Patient Age 63.6 yrs 66.2 yrs
% Female Patients 65.3% 30.6%
FDA Approval Date Nov 1, 2023 May 8, 2014
Manufacturer Phathom Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Prescription Discontinued